Antimicrobial resistance (AMR) is a tremendously important issue on a global scale- drug resistance, specifically to antibiotics, is on the rise, and R&D in antibiotics has not kept up. This AMR ‘gap’ won’t be closed without fixing how returns are awarded; it requires scrapping the traditional approach that ties revenues to volume for an innovative approach that rewards value. ‘Delinkage’ of value and volume is an exciting, emerging topic among those involved in the antibiotic space. This review will attempt to introduce some of the ideas central to resolving the AMR crisis.
Last year, New York City Mayor Michael Bloomberg, attempted to pass legislation prohibiting the sale of soda over 16 ounces in restaurants, movie theaters, and sports arenas. What has since been twice overruled and deemed reflective of an emerging “nanny state” that is “un-American” and “paternalistic,” the “New York City Soda Ban” brought much needed […]
As the Syrian civil war continues, international bodies are taking notice of the atrocities committed on both sides of the conflict. Rape has been used as a weapon of war—a tool of political and social subjugation—and it is one of the most important issues that ought to be addressed by the United Nations and other […]
Medicine in the 21st century continues to advance and bring unprecedented benefits to patients. Many people across the world now have access to safe, high quality healthcare. However, even in the world’s leading healthcare systems, patients still experience needless suffering and harm. This was exemplified by the recent Francis inquiry, which investigated care delivered at […]
As U.S. health care costs continue to increase, the cost of prescription drugs are often a topic of debate surrounding health care reform discussions. Last year, prescription drug expenditures exceeded $326 billion, which accounted for approximately 11% of total health care expenditures in the U.S.1 With costs only expected to increase over the next several […]
With HIV infection rates persisting at high levels in the United States, it’s time we faced the facts. Science and policy are disconnected. In the United States, the sharing of contaminated needles during injection drug use accounts for 7-14% of new HIV infections each year.
HHPR hosted an open lunch with Professor Benjamin Sommers, M.D., Ph.D. December 7, 2012 1:00PM-2:00PM Eliot Memorial Dining Hall Benjamin Sommers, M.D., Ph.D is an Assistant Professor of Health Policy and Economics at the Harvard School of Public Health. His research focuses on addressing barriers to care for low-income Americans and the uninsured especially […]
HHPR hosted an open Student Mental Health Policy Panel December 3, 2012 7:30PM-9:00PM Eliot JCR Featuring Distinguished Speakers: Dr. Paul Barreira Director, Harvard UHS Dr. Catherine Bell Coordinator of College Mental Health Program, McLean Hospital Dr. David Rosmarin Department of Psychiatry, Harvard Medical School The speakers’ presentations were followed by a wonderful open discussion with […]
The cost of health care in the U.S. is spiraling out of control. One of the many contributing factors to escalating costs often cited by health policy experts is the fee-for-service payment system. FFS rewards providers based on the quantity rather than the quality of care delivered. As a result, our country suffers from widespread overutilization of medical services…
Welcome to the Harvard Health Policy Review’s Blog! This is a forum for staff members of the Harvard Health Policy Review to discuss and comment on all things concerning health policy from an interdisciplinary perspective. Topics will include but are not limited to health care, economics, medical sociology, bioethics, drug development, and political analysis. We hope to bring you interesting […]
Latest HHPR Online Posts
Archive of Previous Posts
CategoriesHealth LawPrimary Health CareHealth Reform and SystemsEconomicsGlobal Health CareHealth Reforms and SystemsNational Health Care